Figure S2 from Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade
Authors:
- Samuel RosnerSRSamuel Rosner
- Sydney ConnorSCSydney Connor
- Khaled SanberKSKhaled Sanber
- Marianna ZahurakMZMarianna Zahurak
- Tianbei ZhangTZTianbei Zhang
- Isha GurumurthyIGIsha Gurumurthy
- Zhen ZengZZZhen Zeng
- Brad PressonBPBrad Presson
- Dipika SinghDSDipika Singh
- Roni RayesRRRoni Rayes
- Lavanya SivapalanLSLavanya Sivapalan
- Gavin PereiraGPGavin Pereira
Open Access
- 17 January 2025
- other
- Published by American Association for Cancer Research (AACR)